| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258K | — | -69.4% |
| Cost of Revenue | $184K | — | -48.3% |
| Gross Profit | $74K | — | -84.8% |
| R&D Expense | $14.5M | — | +5.6% |
| SG&A Expense | $9.6M | — | -18.9% |
| Operating Income | -$24.1M | — | +4.2% |
| Pre-tax Income | -$21.8M | — | -13.6% |
| Income Tax | -$122K | — | -1209.1% |
| Net Income | -$21.7M | — | -12.9% |
| EPS (Basic) | -$0.10 | — | +9.1% |
| EPS (Diluted) | -$0.10 | — | +9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +67.3% | -2.9% |
| Accounts Receivable | $203K | -63.8% | -80.3% |
| Inventory | $2.2M | -31.5% | -50.5% |
| Current Assets | $135.0M | -23.3% | -44.2% |
| Total Assets | $213.3M | -13.1% | -21.3% |
| Current Liabilities | $10.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.6M | — | +2.0% |
| Capital Expenditures | $279K | — | -78.7% |
| Investing Cash Flow | $40.3M | — | +217.8% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$25.9M | — | +5.6% |
| -14.8% |
| Total Liabilities | $12.6M | -50.3% | -48.1% |
| Stockholders' Equity | $200.7M | -8.8% | -18.7% |